Procurement Summary
Country: Kazakhstan
Summary: Purchase of Medicines for Laboratories, Amt: 4891583.79
Deadline: 28 Nov 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 131008624
Document Ref. No.: 15760692-1
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 4891583.79
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Lots: Probe-tampon in a test tube, sterile, without transport medium, packing 100 pcs | Set of reagents for typing (identification of subtypes H1N 1 and H3N 2) of influenza A viruses (Influenza virus A) by PCR with GFL detection in influenza virus cultures and in clinical material containing RNA of influenza viruses A. Set of 55 definitions | The reagent kit is intended for high-quality detection of SARS-CoV-2 coronavirus RNA in biological material (nasopharyngeal and oropharyngeal swabs, sputum) in the diagnosis of persons with clinical symptoms of a respiratory disease with suspected COVID-19 infection or persons who do not have signs of colds and are not in contact with patients with COVID-19 using RT-PCR with real-time hybridization-fluorescence detection. Fully equipped with a kit for extraction (isolation) of total RNA/DNA from clinical material (plasma peripheral blood, cerebrospinal fluid, amniotic fluid, nasal swabs, throat swabs, saliva), for subsequent analysis by reverse transcription and polymerase chain reaction. Set of 100 definitions | The set of reagents is intended for the detection and differentiation of RNA of influenza A and B viruses in biological material (smears from the mucous membrane of the nasopharynx and oropharynx, sputum), by RT-PCR with hybridization-fluorescent detection of amplification products in real time. Fully equipped with a kit for extraction (isolation) of total RNA/DNA from clinical material (plasma peripheral...
Documents
Tender Notice